GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthEquity Inc (NAS:HQY) » Definitions » Mohanram G-Score

HealthEquity (HealthEquity) Mohanram G-Score : 5 (As of Jan. 2024)


View and export this data going back to 2014. Start your Free Trial

What is HealthEquity Mohanram G-Score?

Mohanram G-Score is a financial indicator developed by professor Partha Mohanram to help investors find the best investment opportunities in the growth stocks. Companies have higher G-score tends to generate higher return. According to his study, the best growth stocks that have a G-Score greater than 6 tend to beat the market, while those with a G-Score lower than 1 tend to have negative absolute returns.

Thus, the zones of discrimination were as such:

Good or high score = 6, 7, 8
Bad or low score = 0, 1

HealthEquity has an G-score of 5.

The historical rank and industry rank for HealthEquity's Mohanram G-Score or its related term are showing as below:

HQY' s Mohanram G-Score Range Over the Past 10 Years
Min: 5   Med: 5   Max: 6
Current: 5

During the past 12 years, the highest Piotroski G-score of HealthEquity was 6. The lowest was 5. And the median was 5.


HealthEquity Mohanram G-Score Historical Data

The historical data trend for HealthEquity's Mohanram G-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HealthEquity Mohanram G-Score Chart

HealthEquity Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Mohanram G-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 5.00 5.00 5.00 5.00

HealthEquity Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Mohanram G-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 5.00 5.00 5.00 5.00

Competitive Comparison of HealthEquity's Mohanram G-Score

For the Health Information Services subindustry, HealthEquity's Mohanram G-Score, along with its competitors' market caps and Mohanram G-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthEquity's Mohanram G-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Mohanram G-Score distribution charts can be found below:

* The bar in red indicates where HealthEquity's Mohanram G-Score falls into.



HealthEquity Mohanram G-Score Calculation

The calculation of the Mohanram G-score consists of eight criteria. Assign one point for each criterion met, then add up all the points to get the G-Score.

Profitability

Question 1. Return on Assets (ROA)

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. It measures how well a company uses its asset to generate earnings.

Score 1 if ROA > ROA Industry Median, 0 otherwise.

Question 2. Cash ROA

Cash ROA equals to Cash Flow from Operations divided by average Total Assets. It measures how well a company uses its asset to generate cash.

Score 1 if Cash ROA > Cash ROA Industry Median, 0 otherwise.

Question 3. CFO and Net Income

Score 1 if CFO > Net Income, 0 otherwise.

Earnings Predictability

Question 4. Earnings Variability

Earnings Variability is measured as the variance of a firm's ROA in the past five years.

Score 1 if Earnings Variability < Earnings Variability Industry Median, 0 otherwise.

Question 5. Sales Growth Variability

Sales Growth Variability is measured as the 5-year variance in sales growth.

Score 1 if Sales Growth Variability < Sales Growth Variability Industry Median, 0 otherwise.

Accounting Conservatism

Question 6. Research & Development Intensity

Research & Development Intensity is calcualted by Research & Development divided by the beginning Total Assets.

Score 1 if Research & Development Intensity > Research & Development Intensity Industry Median, 0 otherwise.

Question 7. CAPEX Intensity

CAPEX Intensity is calcualted by Capital Expenditure divided by the beginning Total Assets.

Score 1 if CAPEX Intensity > CAPEX Intensity Industry Median, 0 otherwise.

Question 8. Advertising Expenditure Intensity

Advertising Expenditure Intensity is calcualted by Advertising Expenditure divided by the beginning Total Assets. Note that Advertising Expenditure is not reported as a seperate line item for many companies, thus Selling, General, & Admin. Expense is used in this calculation.

Score 1 if Advertising Expenditure Intensity > Advertising Expenditure Intensity Industry Median, 0 otherwise.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note that all the Industry Median used for comparison in his original research, are substituted with Sector Median due to the limitation of data within certain countries.

Good or high score = 6, 7, 8
Bad or low score = 0, 1

HealthEquity has an G-score of 5.

HealthEquity  (NAS:HQY) Mohanram G-Score Explanation

Partha Mohanram is the John H. Watson Chair in Value Investing at Rotman and the Acting Vice-Dean of Research Strategy and Resources.

In 2000, he wrote a research paper called "Separating Winners from Losers Among Low Book-to-Market Stocks Using Financial Statement Analysis".

This paper tests whether a strategy based on financial statement analysis of low book-to-market (growth) stocks is successful in differentiating between winners and losers in terms of future stock performance. Based on the research, a strategy based on buying high G-score (6, 7 or 8) firms and shorting low G-score (0 or 1) firms consistently earns significant excess returns. Further, the results do not support a risk based explanation for the book-to-market effect as the strategy returns positive returns in all years, and firms that ex-ante appear less risky have better future returns.

To conclude, one can use a modified fundamental analysis strategy (G-score) to identify mispricing and earn substantial abnormal returns.


HealthEquity Mohanram G-Score Related Terms

Thank you for viewing the detailed overview of HealthEquity's Mohanram G-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


HealthEquity (HealthEquity) Business Description

Traded in Other Exchanges
Address
15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. Its technology allows customers to see their tax-advantaged healthcare savings, compare treatment options and pricing, pay healthcare bills, receive benefit information, and earn wellness incentives. The firm primarily partners with health plans and employers and serves as the custodian of its customers' health savings accounts (HSAs). HealthEquity also engages in reimbursement arrangements and offers healthcare incentives to its members. In addition, the company provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Executives
Delano Ladd officer: Executive VP, GC & Corp. Secy. 15W. SCENIC POINTE DR., SUITE 100, DRAPER UT 84020
Ian Sacks director TOWERBROOK CAP., PARK AVENUE TOWER, 65 E 55TH ST., 27TH FLOOR, NEW YORK NY 10022
Elimelech Rosner officer: EVP, Chief Technology Officer 5196 BELMORE COURT, SUWANEE GA 30024
Stephen Neeleman director, officer: Founder and Vice Chairman 15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Tyson D. Murdock officer: EVP & CFO 2275 S. 2200 E., SALT LAKE CITY UT 84109
Jon Kessler director, officer: President and CEO 15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Frank Corvino director GREENWICH HOSPITAL, 5 PERRYRIDGE ROAD, GREENWICH CT 06830
Larry L Trittschuh officer: EVP Chief Security Officer 1051 RUNNYMEDE ROAD, OAKWOOD OH 45419
James M Lucania officer: EVP & CFO 101 WOLF DRIVE, THOROFARE NJ 08086
Gayle Furgurson Wellborn director 123 TORRENCE CHAPEL ROAD, MOORESVILLE NC 28117
Debra Charlotte Mccowan director 1436 CABRILLO AVENUE, BURLINGAME CA 94010
Paul Black director 400 WOOD ROAD, BRAINTREE MA 02184
Edward Bloomberg officer: Chief Operating Officer 13207 WINDSOR STREET, LEAWOOD KS 66209
Rajesh Natarajan director 7500 DALLAS PARKWAY, SUITE 700, PLANO TX 75024
Evelyn S Dilsaver director C/O LONGS DRUG STORES CORPORATION, 141 NORTH CIVIC DRIVE, WALNUT CREEK CA 94596